Tenax Therapeutics Inc. (TENX) Plummeted To A New Low On Study Results

Henrietta Brewer
February 2, 2017

The forecast of 2 surveyed investment analysts covering the stock advises investors to Buy stake in the company. The share price of $1.14 is at a distance of 11.76 percent from its 52-week low and down -60.69 percent versus its peak.

Tenax Therapeutics, Inc. (TENX) recently recorded -9.72 percent change and now at $1.95 is 61.16 percent away from its 52-week low and down -33.67 percent versus its peak.

The consensus mean EPS for the current quarter is at $-0.15 derived from a total of 2 estimates. The company's stock has grown by -20.77 percent in the past 5 years. The stock tapped a 52-week high of US$43.36 while the mean 12-month price target for the shares is US$41. The last trading session volume compares with the 416.55K average and market worth floats around 12.93M. (TENX) is getting stronger by the somewhat negative sentiment (1.50 on a 5-point scale) that sell-side analysts have provided concerning it. WallachBeth has been covering shares of TENX, so it is most recent view is worth a look. The company reported its last quarter on Sep 16.

Tenax Therapeutics, Inc. has a 50 day moving average of 2.13 and a 200 day moving average of 2.12.

United States of America based company, Tenax Therapeutics, Inc.'s (TENX)'s latest closing price distance was at -79.93% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at -77.10% and -79.08% compared with the 20 Day Moving Average. The median estimate represents a +1,910.87% increase from the last price of 0.46. The share price is now -22.84 percent versus its SMA20, -27.44 percent versus its SMA50, and -42.18 percent versus its SMA200. The Stock has YTD (year to date) performance of -76.41 percent.

Tenax Therapeutics, Inc. Gross Margin percentage stands at 0% while its Operating Margin for trailing twelve month is 0 percent and Profit margin (ttm) is 0 Percent. The stock touched its high share price of $2.94 on April 14, 2016 and the stock also touched its Lowest price in the last 52-weeks of trading on Jan 31, 2017 as $0.42. The stock is now moving above its 20-Day Simple Moving Average of -77.1% with the 50-Day Simple Moving Average of -77.1 percent. Relative volume is ratio between current volume and 3-month average value, intraday adjusted. The stock has its Price to Earnings (P/E) ratio of 0 and Forward Price to Earnings ratio of 0. 2 assigned the recommendations about the stock as a "Buy" signal and "Overweight" signal was reported by 0. The stock is a Buy among 14 brokerage firms polled by Factset Research. Another insider trade includes Director Proehl (Gerald T) who also initiated a transaction in which 14449 shares were traded on 22 Nov 2016 as "Buy".

Other reports by iNewsToday